Clinical trial

Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00876694

Study summary

ClinicalTrials.gov

Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Indacaterol 300 µg Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Salmeterol 50 µg Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-03-01

PhasePHASE3

Conditions

Chronic Obstructive Pulmonary Disease (COPD)verified · MONDO: chronic obstructive pulmonary disease

Interventions

Indacaterol 300 µgDRUG

Salmeterol 50 µgDRUG

Sponsors & collaborators

Novartis Pharmaceuticalslead sponsor

Mapped research locations

TokyoJapan1 KyotoJapan1 HiroshimaJapan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00876694 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.